Tenders Are Invited For The Contracting Of Supply Of Reagents, Antibodies, Columns, Media And Materials Necessary For Immunomagnetic Cell Separation, Advanced Cell Culture And Cell Processing Procedures Necessary To Carry Out The Research Project Ci23/00041 Intratumoral Administration Of T Cells Modified With The Chimeric Receptor (Car) Against The P32 Antigen In High-Grade Gliomas In Progression. Phase 1 Clinical Trial With Dose Escalation Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union, To Be Awarded By The Biomedical Research Foundation Of The Doce De Octubre University Hospital By Procedure (Sara) Single Price Criterion Fib 2025/033.
Tenders Are Invited For The Contracting Of Supply Of Reagents, Antibodies, Columns, Media And Materials Necessary For Immunomagnetic Cell Separation, Advanced Cell Culture And Cell Processing Procedures Necessary To Carry Out The Research Project Ci23/00041 Intratumoral Administration Of T Cells Modified With The Chimeric Receptor (Car) Against The P32 Antigen In High-Grade Gliomas In Progression. Phase 1 Clinical Trial With Dose Escalation Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union, To Be Awarded By The Biomedical Research Foundation Of The Doce De Octubre University Hospital By Procedure (Sara) Single Price Criterion Fib 2025/033.
The Contracting Of Supply Of Reagents, Antibodies, Columns, Media And Materials Necessary For Immunomagnetic Cell Separation, Advanced Cell Culture And Cell Processing Procedures Necessary To Carry Out The Research Project Ci23/00041 Intratumoral Administration Of T Cells Modified With The Chimeric Receptor (Car) Against The P32 Antigen In High-Grade Gliomas In Progression. Phase 1 Clinical Trial With Dose Escalation Financed By The Carlos Iii Health Institute (Isciii) And Co-Financed By The European Union, To Be Awarded By The Biomedical Research Foundation Of The Doce De Octubre University Hospital By Procedure (Sara) Single Price Criterion Fib 2025/033.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
